IPA, an artificial intelligence-driven biotherapeutic research and technology company, announced the development of a Foundation AI Model that represents a significant advancement in life sciences research and development. The Company’s model uniquely combines the strengths of Large Language Models (LLMs) through an advanced stacking technique with BioStrand's patented HYFT...
Genesis Therapeutics, a company pioneering generative and predictive artificial intelligence (AI) technologies to develop breakthrough therapeutics for underserved patient populations, announced that Fierce Medtech has named it as one of 2023’s “Fierce 15” medtech companies. The annual special report features the most innovative private companies in the industry.
Genesis has...
Helix, the leading population genomics company in the nation, announced that Hylton Kalvaria has joined its leadership team as senior vice president (SVP) of Life Sciences. Kalvaria will oversee partnerships leveraging the unique and growing clinico-genomic datasets of Helix with life sciences customers.
Kalvaria brings a wealth of executive experience...
BIOHM Health Inc., a leading innovator in, and patent holder of, microbiome-based products and ingredients, has announced a partnership with Virginia Tech to further enhance its pioneering Symbiont platform through the use of artificial intelligence (A.I.). Symbiont, which has been peer reviewed in Gastroenterology, is a process which identifies and selects ingredients...
Ibex Medical Analytics, the leader in AI-powered cancer diagnostics, and PathPresenter, the global image sharing platform for pathology, announced a partnership to advance the adoption of AI-powered digital pathology. The two companies will work together to support joint customers via an AI-powered digital pathology solution for laboratories, hospitals and health...
PreemptiveAI, an innovative AI research and development company driven by a mission to extend human life and boasting multiple scientific breakthroughs, is thrilled to announce its emergence from stealth mode. Based in Seattle, WA and backed by an initial $6.4M in funding, the company is unveiling a revolutionary foundation model aimed at transforming...
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, NEC Corporation, a leader in IT, network and AI technologies and BostonGene Corporation (BostonGene), a leading company in AI-based molecular and immune profiling, announced the expansion of their collaboration for the randomized Phase I/II...
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced a new release of Genedata Screener®, its enterprise platform for automated assay data analytics and consolidated assay information management across an enterprise. The new version features as a new module, Assay Performance Monitoring, the first commercially available...
Eurofins Discovery, part of the Eurofins network of laboratories and an industry-leading provider of products and services for drug discovery research, announces the launch of DiscoveryAI SAFIRE (Suite of ADMET Predictions For In Silico Refinement and Evaluation). SAFIRE is an advanced platform that leverages proprietary datasets, artificial intelligence (AI), and machine learning (ML), offering...
New Chat-based AI Interface Allows Life Sciences Executives to Unlock the Collective Power of All Their Brand Research
Trinity Life Sciences, a leader in global life sciences commercialization solutions, launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research. Designed by experts...
